In EBV-positive HIV-associated DLBCL, mutations in JAK/STAT pathway also leads to abnormal activation and elevated expression of downstream oncogenes, such as c-MYC, thereby resulting in the progression of malignant tumors [37, 38]. This evidence concerns the gene MYC and cancer.